Schrodinger Inc. (SDGR): Price and Financial Metrics
Schrodinger Inc. (SDGR)
Today's Latest Price: $84.01 USD
Updated Jan 27 6:55pm
Add SDGR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 78 in Medical - Services
See all "A" rated Strong Buy stocks
SDGR Stock Summary
- SDGR's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.6 -- higher than just 5.86% of US-listed equities with positive expected earnings growth.
- SDGR's went public 0.98 years ago, making it older than just 0.14% of listed US stocks we're tracking.
- SDGR's price/sales ratio is 57.86; that's higher than the P/S ratio of 94.9% of US stocks.
- Stocks that are quantitatively similar to SDGR, based on their financial statements, market capitalization, and price volatility, are IDN, BLDP, ALTR, INTZ, and LQDT.
- SDGR's SEC filings can be seen here. And to visit Schrodinger Inc's official web site, go to www.schrodinger.com.
SDGR Stock Price Chart Interactive Chart >
SDGR Price/Volume Stats
| Current price | $84.01 | 52-week high | $100.75 |
| Prev. close | $93.45 | 52-week low | $25.50 |
| Day low | $82.81 | Volume | 1,664,200 |
| Day high | $93.00 | Avg. volume | 765,194 |
| 50-day MA | $77.08 | Dividend yield | N/A |
| 200-day MA | $66.47 | Market Cap | 5.84B |
Schrodinger Inc. (SDGR) Company Bio
Schrödinger, Inc. provides chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development
Loading social stream, please wait...